ERBB2 and cancer: Studies indicated a positive correlation between suppression of the human epidermal growth factor receptor 2 (HER2)/PI3K/Akt pathway and PD-L1 expression [74, 75], with heat shock protein 90 (HSP90) regulating tumor expression in certain cancers [76].